MolNFT v1 · #147959 · protein
Structure of the phosphate-bound form of aiox from rhizobium sp. str. nt-26
6ESV · Putative periplasmic phosphite-binding-like protein (pbl)…: “Structure of the phosphate-bound form of aiox from rhizobium sp. str. nt-26”. X-ray diffraction, 1 ligand (PO4), 1 pocket (best druggability 0.79). MolNFT v1 #147959 on…
- PDB
- 6ESV
- Type
- protein
- Length
- 261 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Putative periplasmic phosphite-binding-like protein (pbl) ptxb-like protein designated…
- UniProt
- L0NML6
- Ligands
- PO4
- Pockets
- 1 · best druggability 0.79
Structure
x-ray diffraction · 1 distinct chain · 46% helix, 23% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Putative periplasmic phosphite-binding-like protein (pbl) ptxb-like protein designated aiox | protein | 261 | 46% helix, 23% strand | L0NML6 |
Ligands and binding sites
- PO4 · Phosphate ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 370 | 0.79 | 0.88 | 44 | PO4 |
Modifications
Observed in the structure: 5 modified (engineered).
Compared structures
- 6ESV · Structure of the phosphate-bound form of AioX from Rhizobium sp. str. NT-26 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt L0NML6
- Elsewhere: RCSB PDB 6ESV · PDBe 6ESV · UniProt L0NML6
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.